| 1 |
33837914 | Potential Diagnostic Significance of Salivary Copper Determination in Breast Cancer Patients: A Pilot Study. | 2022 Mar |
1 |
| 2 |
34911733 | Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer. | 2022 Apr 1 |
1 |
| 3 |
34990895 | Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer. | 2022 Jan |
1 |
| 4 |
35052843 | Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes. | 2022 Jan 13 |
2 |
| 5 |
35173185 | Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer. | 2022 Feb 16 |
1 |
| 6 |
35217253 | A novel peptide-based electrochemical biosensor for breast cancer characterization over a poly 3-(3-aminophenyl) propionic acid matrix. | 2022 Jun 1 |
1 |
| 7 |
35218811 | Quantitative analysis of breast cancer tissue composition and associations with tumor subtype. | 2022 May |
2 |
| 8 |
35227076 | Androgen receptor expression and its prognostic value in T1N0 luminal/HER2- breast cancer. | 2022 May |
1 |
| 9 |
35248133 | INHBA is a mediator of aggressive tumor behavior in HER2+ basal breast cancer. | 2022 Mar 5 |
1 |
| 10 |
35371692 | Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Low Status in Response to Neoadjuvant Chemotherapy in Early Breast Cancer. | 2022 Feb |
1 |
| 11 |
35430163 | Overall Survival for HER2-Positive Breast Cancer Patients in the HER2-Targeted Era: Evidence From a Population-Based Study. | 2022 Jul |
1 |
| 12 |
35459982 | CCND1 Amplification in Breast Cancer -associations With Proliferation, Histopathological Grade, Molecular Subtype and Prognosis. | 2022 Mar |
2 |
| 13 |
35633393 | Newly identified breast luminal progenitor and gestational stem cell populations likely give rise to HER2-overexpressing and basal-like breast cancers. | 2022 May 28 |
1 |
| 14 |
32859560 | The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes. | 2021 Mar |
1 |
| 15 |
33280209 | Relationship between lymphovascular invasion and molecular subtypes in invasive breast cancer. | 2021 Apr |
1 |
| 16 |
33397968 | Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer. | 2021 Jan 4 |
2 |
| 17 |
33446633 | Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis. | 2021 Jan 14 |
1 |
| 18 |
33472889 | Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling. | 2021 Mar 15 |
1 |
| 19 |
33571253 | A mixture model to detect edges in sparse co-expression graphs with an application for comparing breast cancer subtypes. | 2021 |
1 |
| 20 |
33579951 | Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer. | 2021 Feb 12 |
1 |
| 21 |
33616774 | DTX3 copy number increase in breast cancer: a study of associations to molecular subtype, proliferation and prognosis. | 2021 May |
1 |
| 22 |
33763657 | A single-cell atlas of the healthy breast tissues reveals clinically relevant clusters of breast epithelial cells. | 2021 Mar 16 |
1 |
| 23 |
33816261 | Impact of Postoperative Radiotherapy on Survival of Patients With de novo Stage IV Breast Cancer: A Population-Based Study From the SEER Database. | 2021 |
1 |
| 24 |
33917614 | Association of Vitamin D Receptor and Vitamin D-Binding Protein Polymorphisms with Familial Breast Cancer Prognosis in a Mono-Institutional Cohort. | 2021 Apr 6 |
1 |
| 25 |
33919875 | Dendritic Cells Are Associated with Prognosis and Survival in Breast Cancer. | 2021 Apr 14 |
1 |
| 26 |
33948296 | Stereotactic radiosurgery for patients with breast cancer brain oligometastases - molecular subtypes and clinical outcomes. | 2021 |
1 |
| 27 |
34054952 | Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience. | 2021 |
1 |
| 28 |
34073233 | KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer. | 2021 May 26 |
2 |
| 29 |
34086481 | Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay-Results From the SAFIA Phase III Trial. | 2021 Jun |
1 |
| 30 |
34183353 | Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative. | 2021 Nov |
1 |
| 31 |
34221828 | HER2-positive breast cancer in a germline BRCA1 gene large deletion carrier. | 2021 Jul |
1 |
| 32 |
34244869 | Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients. | 2021 Sep |
1 |
| 33 |
34273808 | Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium: a population-based study. | 2021 Aug |
1 |
| 34 |
34609431 | Analysis of breast cancer subtypes and their correlations with receptors and ultrasound. | 2021 Jan-Mar |
1 |
| 35 |
34675248 | Dual recombinase action in the normal and neoplastic mammary gland epithelium. | 2021 Oct 21 |
1 |
| 36 |
31959756 | Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade. | 2020 Jan 20 |
1 |
| 37 |
32191225 | The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes. | 2020 Mar 18 |
1 |
| 38 |
32296584 | Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance. | 2020 Feb 15 |
1 |
| 39 |
32461977 | Efficacy of Neoadjuvant Chemotherapy with Epirubicin and Cyclophosphamide and Weekly Paclitaxel and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Carcinoma: A Real-World Study. | 2020 |
2 |
| 40 |
32467058 | Identification of Luminal Subtypes of Breast Carcinoma Using Surrogate Immunohistochemical Markers and Ascertaining Their Prognostic Relevance. | 2020 Oct |
1 |
| 41 |
32508292 | Combinational Treatment of Doxorubicin With Neoadjuvant Docetaxel for Different Subtypes of Patients With Breast Cancer. | 2020 Jan-Dec |
2 |
| 42 |
32512573 | Insights from a Long-Term Follow-Up Evaluation of Early Breast Cancer Outcomes by Tumor Subtype. | 2020 |
1 |
| 43 |
32546648 | Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5. | 2020 Nov 1 |
2 |
| 44 |
32549380 | Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers. | 2020 Jun 15 |
1 |
| 45 |
32562180 | Correlation between imaging features and molecular subtypes of breast cancer in young women (≤30 years old). | 2020 Nov |
2 |
| 46 |
32601970 | Activation of mitochondrial unfolded protein response is associated with Her2-overexpression breast cancer. | 2020 Aug |
1 |
| 47 |
32737714 | Impact of breast cancer subtype on clinical outcomes after Gamma Knife radiosurgery for brain metastases from breast cancer: a multi-institutional retrospective study (JLGK1702). | 2020 Nov |
2 |
| 48 |
32839004 | Advances in the Molecular Taxonomy of Breast Cancer. | 2020 Nov |
1 |
| 49 |
32888142 | Luminal subtypes and response to neoadjuvant chemotherapy for hormone receptor-positive HER2-negative patients. | 2020 Dec |
1 |
| 50 |
32891135 | Association between levels of tumor-infiltrating lymphocytes in different subtypes of primary breast tumors and prognostic outcomes: a meta-analysis. | 2020 Sep 5 |
1 |